In summary, lncRNA-HNF1A-AS1 acts as a ceRNA that activates PI3K/AKT signalling by competitively binding to miR-30b-3p and exhibits oncogenic properties in GC (Fig. 6q). The gene discussed is HNF1A; the disease is gastric cancer.